Rasaq Abiola Ojasanya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rasaq Abiola Ojasanya has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
J. Scott Weese
3 shared publicationsKurtis E. Sobkowich
3 shared publicationsTheresa M. Bernardo
3 shared publicationsZvonimir Poljak
3 shared publicationsAndy Plum
2 shared publicationsAnne Deckert
2 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by Elsevier in Preventive Veterinary Medicine
- Vol. 257
Epidemiologic determinants of antimicrobial resistance in feline urinary Escherichia coli in the United States (2018–2024)
- 15 October 2026
- Published by Elsevier in Preventive Veterinary Medicine
- Vol. 257
Open AccessEpidemiologic determinants of antimicrobial resistance in feline urinary Escherichia coli in the United States (2018–2024)
- Open Access
- 24 June 2026
- Published by Springer Nature in BMC Veterinary Research
- Vol. 22 (1)
Exploratory analysis of risk factors associated with antimicrobial resistance in urinary Escherichia coli from dogs in the United States (2018–2024)
Background: Bacterial cystitis, predominantly caused by Escherichia coli , is a leading cause for antimicrobial prescriptions in dogs. The use of antimicrobials contributes to selection pressure for antimicrobial resistance (AMR), a growing concern for veterinary and public health. This study examined risk factors for resistance in urinary E. coli isolates from dogs in the United States, focusing on prior positive cultures and other host, socioeconomic, and geographic factors using data from a national commercial diagnostic laboratory. Associations between selected exposures of interest and AMR were assessed using multilevel logistic regression models, accounting for clustering at the patient, county, and state levels. Results: A total of 393,972 clinical urinary E. coli isolates from 339,977 dogs across the United States, submitted between 2018 and 2024, were tested for antimicrobial susceptibility. Resistance was highest to amoxicillin (27.39%; 95% CI: 27.25–27.53). When examined in multilevel logistic regression models, and across all antimicrobials, the greatest proportion of variance occurred at the patient level (range: 22.2–46.1%). The log odds of detecting resistance increased linearly with the number of prior positive cultures in the previous six months. After adjusting for all other covariates, every 1% increase in the annual county-level percentage of dogs with positive culture and antimicrobial susceptibility test was associated with a 1–2% decrease in the odds of resistance across all antimicrobials (OR range: 0.98–0.99; p < 0.001). States with 1,500–1,999 housing units per veterinarian had higher odds of marbofloxacin resistance (OR: 1.85, 95% CI: 1.20–2.85, adjusted p = 0.027) than states with 500–999 units, a pattern consistent across other antimicrobials. Conclusion: Patient-level factors, particularly recent repeated positive cultures examined in this study, are associated with AMR in canine urinary E. coli , likely reflecting cumulative antimicrobial exposure and/or chronic resistant infections. Additionally, lower odds of detecting AMR were observed in counties with higher microbiological testing frequency and in states with higher veterinarian density, which may reflect differences in access to veterinary care or diagnostic practices. However, because these variables are measured at the group level, they do not capture individual-level veterinary care. Further research incorporating patient-level measures of care access and prescribing practices will be crucial.
- 24 June 2026
- Published by Springer Nature in BMC Veterinary Research
- Vol. 22 (1)
Open AccessExploratory analysis of risk factors associated with antimicrobial resistance in urinary Escherichia coli from dogs in the United States (2018–2024)
Background: Bacterial cystitis, predominantly caused by Escherichia coli , is a leading cause for antimicrobial prescriptions in dogs. The use of antimicrobials contributes to selection pressure for antimicrobial resistance (AMR), a growing concern for veterinary and public health. This study examined risk factors for resistance in urinary E. coli isolates from dogs in the United States, focusing on prior positive cultures and other host, socioeconomic, and geographic factors using data from a national commercial diagnostic laboratory. Associations between selected exposures of interest and AMR were assessed using multilevel logistic regression models, accounting for clustering at the patient, county, and state levels. Results: A total of 393,972 clinical urinary E. coli isolates from 339,977 dogs across the United States, submitted between 2018 and 2024, were tested for antimicrobial susceptibility. Resistance was highest to amoxicillin (27.39%; 95% CI: 27.25–27.53). When examined in multilevel logistic regression models, and across all antimicrobials, the greatest proportion of variance occurred at the patient level (range: 22.2–46.1%). The log odds of detecting resistance increased linearly with the number of prior positive cultures in the previous six months. After adjusting for all other covariates, every 1% increase in the annual county-level percentage of dogs with positive culture and antimicrobial susceptibility test was associated with a 1–2% decrease in the odds of resistance across all antimicrobials (OR range: 0.98–0.99; p < 0.001). States with 1,500–1,999 housing units per veterinarian had higher odds of marbofloxacin resistance (OR: 1.85, 95% CI: 1.20–2.85, adjusted p = 0.027) than states with 500–999 units, a pattern consistent across other antimicrobials. Conclusion: Patient-level factors, particularly recent repeated positive cultures examined in this study, are associated with AMR in canine urinary E. coli , likely reflecting cumulative antimicrobial exposure and/or chronic resistant infections. Additionally, lower odds of detecting AMR were observed in counties with higher microbiological testing frequency and in states with higher veterinarian density, which may reflect differences in access to veterinary care or diagnostic practices. However, because these variables are measured at the group level, they do not capture individual-level veterinary care. Further research incorporating patient-level measures of care access and prescribing practices will be crucial.
- Open Access
- 4 September 2025
- Published by Elsevier in Preventive Veterinary Medicine
- Vol. 245, 106684
Assessment of seasonality in antimicrobial susceptibility testing and resistance of urinary Escherichia coli from dogs and cats in the United States (2019 – 2022)
- 4 September 2025
- Published by Elsevier in Preventive Veterinary Medicine
- Vol. 245, 106684
Open AccessAssessment of seasonality in antimicrobial susceptibility testing and resistance of urinary Escherichia coli from dogs and cats in the United States (2019 – 2022)
- Open Access
- 30 May 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (5) , e0323246
Antimicrobial-resistance of Escherichia coli in dogs and cats: A scoping review
Pathogenic Escherichia coli causes a range of clinical manifestations in dogs and cats, and the use of antimicrobials in pets is associated with the risk of antimicrobial resistance (AMR). Pets contribute to the dissemination of AMR both within their species and to humans. This study conducts a scoping review to assess the existing evidence on the AMR of E. coli in dogs and cats, noting the purpose of antimicrobial susceptibility testing (AST) and determining the knowledge gaps to inform future research. The search utilized specific and generic strings aligned with the research objectives, spanning databases such as MEDLINE®, Web of Science, Biological Science Collection, AGRICOLA, CAB Direct, and Google Scholar, from January 1990 to July 2023. The study selection included only articles published in English and related to primary research. Following deduplication, the initial search identified 1,205 studies. After a detailed full-text review, 108 independent studies were identified. Studies on the AMR of E. coli in companion animals are largely concentrated in North America and Western Europe. Most of the studies were observational and were conducted in veterinary clinics. AST was primarily conducted to guide the antimicrobial treatment of E. coli infections in pets. Although not all studies provided clinical histories, among those that did, multi-drug resistant (MDR) E. coli was reported in both healthy and ailing pets. The detection of MDR E. coli in healthy and sick pets serve as a clarion call for antimicrobial stewardship. However, the limited number of studies dedicated to AMR monitoring and surveillance programs for companion animals raises a substantial concern.
- 30 May 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (5) , e0323246
Open AccessAntimicrobial-resistance of Escherichia coli in dogs and cats: A scoping review
Pathogenic Escherichia coli causes a range of clinical manifestations in dogs and cats, and the use of antimicrobials in pets is associated with the risk of antimicrobial resistance (AMR). Pets contribute to the dissemination of AMR both within their species and to humans. This study conducts a scoping review to assess the existing evidence on the AMR of E. coli in dogs and cats, noting the purpose of antimicrobial susceptibility testing (AST) and determining the knowledge gaps to inform future research. The search utilized specific and generic strings aligned with the research objectives, spanning databases such as MEDLINE®, Web of Science, Biological Science Collection, AGRICOLA, CAB Direct, and Google Scholar, from January 1990 to July 2023. The study selection included only articles published in English and related to primary research. Following deduplication, the initial search identified 1,205 studies. After a detailed full-text review, 108 independent studies were identified. Studies on the AMR of E. coli in companion animals are largely concentrated in North America and Western Europe. Most of the studies were observational and were conducted in veterinary clinics. AST was primarily conducted to guide the antimicrobial treatment of E. coli infections in pets. Although not all studies provided clinical histories, among those that did, multi-drug resistant (MDR) E. coli was reported in both healthy and ailing pets. The detection of MDR E. coli in healthy and sick pets serve as a clarion call for antimicrobial stewardship. However, the limited number of studies dedicated to AMR monitoring and surveillance programs for companion animals raises a substantial concern.
- Open Access
- 9 July 2024
- Published by Wiley in Veterinary Medicine and Science
- Vol. 10 (4) , e1530
Retrospective study on the occurrence of Salmonella serotypes in veterinary specimens of Atlantic Canada (2012–2021)
Aim: This study aimed to summarize the frequency and the antimicrobial susceptibility profiles of the Salmonella serotypes identified from the specimens of companion animals, livestock, avian, wildlife and exotic species within Atlantic Canada.Materials and Methods: The retrospective electronic laboratory data of microbiological analyses of a selected subset of samples from 03 January 2012 to 29 December 2021 submitted from various animal species were retrieved. The frequency of Salmonella serotypes identified, and their antimicrobial susceptibility results obtained using the disk diffusion or broth method were analysed. The test results were interpreted according to the Clinical and Laboratory Standards Institute standard. The Salmonella serotypes were identified by slide agglutination (Kauffman–White‐Le‐Minor Scheme) and/or the Whole Genome Sequencing for the Salmonella in silico Serovar Typing Resource–based identification.Results: Of the cases included in this study, 4.6% (n = 154) had at least one Salmonella isolate, corresponding to 55 different serovars. Salmonella isolation was highest from exotic animal species (n = 40, 1.20%), followed by porcine (n = 26, 0.78%), and canine (n = 23, 0.69%). Salmonella subsp. enterica serovar Typhimurium was predominant among exotic mammals, porcine and caprine samples, whereas S. Enteritidis was mostly identified in bovine and canine samples. S. Typhimurium of porcine origin was frequently resistant (>70.0%) to ampicillin. In contrast, S. Typhimurium isolates from porcine and caprine samples were susceptible (>70.0%) to florfenicol. S. Oranienburg from equine samples was susceptible to chloramphenicol, but frequently resistant (>90.0%) to azithromycin. In avian samples, S. Copenhagen was susceptible (>90.0%) to florfenicol, whereas Muenchen was frequently resistant (>90.0%) to florfenicol. S. subsp. diarizonae serovar IIIb:61:k:1,5 of ovine origin was resistant (50.0% isolates) to sulfadimethoxine. No significant changes were observed in the antibiotic resistance profiles across the study years.Conclusions: This report provides data for surveillance studies, distribution of Salmonella serotypes and their antimicrobial resistance among veterinary specimens of Atlantic Canada.
- 9 July 2024
- Published by Wiley in Veterinary Medicine and Science
- Vol. 10 (4) , e1530
Open AccessRetrospective study on the occurrence of Salmonella serotypes in veterinary specimens of Atlantic Canada (2012–2021)
Aim: This study aimed to summarize the frequency and the antimicrobial susceptibility profiles of the Salmonella serotypes identified from the specimens of companion animals, livestock, avian, wildlife and exotic species within Atlantic Canada.Materials and Methods: The retrospective electronic laboratory data of microbiological analyses of a selected subset of samples from 03 January 2012 to 29 December 2021 submitted from various animal species were retrieved. The frequency of Salmonella serotypes identified, and their antimicrobial susceptibility results obtained using the disk diffusion or broth method were analysed. The test results were interpreted according to the Clinical and Laboratory Standards Institute standard. The Salmonella serotypes were identified by slide agglutination (Kauffman–White‐Le‐Minor Scheme) and/or the Whole Genome Sequencing for the Salmonella in silico Serovar Typing Resource–based identification.Results: Of the cases included in this study, 4.6% (n = 154) had at least one Salmonella isolate, corresponding to 55 different serovars. Salmonella isolation was highest from exotic animal species (n = 40, 1.20%), followed by porcine (n = 26, 0.78%), and canine (n = 23, 0.69%). Salmonella subsp. enterica serovar Typhimurium was predominant among exotic mammals, porcine and caprine samples, whereas S. Enteritidis was mostly identified in bovine and canine samples. S. Typhimurium of porcine origin was frequently resistant (>70.0%) to ampicillin. In contrast, S. Typhimurium isolates from porcine and caprine samples were susceptible (>70.0%) to florfenicol. S. Oranienburg from equine samples was susceptible to chloramphenicol, but frequently resistant (>90.0%) to azithromycin. In avian samples, S. Copenhagen was susceptible (>90.0%) to florfenicol, whereas Muenchen was frequently resistant (>90.0%) to florfenicol. S. subsp. diarizonae serovar IIIb:61:k:1,5 of ovine origin was resistant (50.0% isolates) to sulfadimethoxine. No significant changes were observed in the antibiotic resistance profiles across the study years.Conclusions: This report provides data for surveillance studies, distribution of Salmonella serotypes and their antimicrobial resistance among veterinary specimens of Atlantic Canada.
- Open Access
- 20 October 2022
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 9, 1031373
Development and validation of main spectral profile for rapid identification of Yersinia ruckeri isolated from Atlantic salmon using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) allows rapid and reliable identification of microorganisms. The accuracy of bacterial identification using MALDI-TOF MS depends on main spectral profiles (MSPs) provided in a quality-assured commercial reference library, which requires ongoing improvement. This study aimed to develop and validate an in-house MALDI-TOF MS MSP to rapidly identify Yersinia ruckeri isolated from Atlantic salmon (Salmo salar). The novel MSP was prepared using an isolate of Y. ruckeri recovered from Atlantic salmon and confirmed by 16S rRNA gene sequencing. Subsequently, a validation set which comprises 29 isolates of Y. ruckeri were examined from three fishes: Atlantic salmon (Salmo salar) (n = 26), American eel (Anguilla rostrata) (n = 1), and Atlantic cod (Gadus morhua) (n = 2). These isolates were randomly selected from the Atlantic Veterinary College, Aquatic Diagnostic Services Bacteriology Laboratory's culture collection to validate the novel MSP. Analytical sensitivity of MALDI-TOF MS using the novel MSP to identify the validation set was 86.2%. Repeatability was assessed by acquiring spectra from 30 different spots of a randomly-selected isolate of Y. ruckeri, and analyzed spectra from each spot were compared against the novel MSP. The coefficient of variation was 3.3%. The novel MSP clustered with Bruker MSPs (n = 3) of Y. ruckeri in the reference library and did not falsely identify any closely related bacteria to Y. ruckeri. This study reports the development of a novel MSP of high analytical sensitivity and specificity for rapid identification of Y. ruckeri using MALDI-TOF MS.
- 20 October 2022
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 9, 1031373
Open AccessDevelopment and validation of main spectral profile for rapid identification of Yersinia ruckeri isolated from Atlantic salmon using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) allows rapid and reliable identification of microorganisms. The accuracy of bacterial identification using MALDI-TOF MS depends on main spectral profiles (MSPs) provided in a quality-assured commercial reference library, which requires ongoing improvement. This study aimed to develop and validate an in-house MALDI-TOF MS MSP to rapidly identify Yersinia ruckeri isolated from Atlantic salmon (Salmo salar). The novel MSP was prepared using an isolate of Y. ruckeri recovered from Atlantic salmon and confirmed by 16S rRNA gene sequencing. Subsequently, a validation set which comprises 29 isolates of Y. ruckeri were examined from three fishes: Atlantic salmon (Salmo salar) (n = 26), American eel (Anguilla rostrata) (n = 1), and Atlantic cod (Gadus morhua) (n = 2). These isolates were randomly selected from the Atlantic Veterinary College, Aquatic Diagnostic Services Bacteriology Laboratory's culture collection to validate the novel MSP. Analytical sensitivity of MALDI-TOF MS using the novel MSP to identify the validation set was 86.2%. Repeatability was assessed by acquiring spectra from 30 different spots of a randomly-selected isolate of Y. ruckeri, and analyzed spectra from each spot were compared against the novel MSP. The coefficient of variation was 3.3%. The novel MSP clustered with Bruker MSPs (n = 3) of Y. ruckeri in the reference library and did not falsely identify any closely related bacteria to Y. ruckeri. This study reports the development of a novel MSP of high analytical sensitivity and specificity for rapid identification of Y. ruckeri using MALDI-TOF MS.
- Open Access
- 25 March 2022
- Published by MDPI AG in Veterinary Sciences
- Vol. 9 (4) , 159
Antimicrobial Susceptibility Profiles of Bacteria Commonly Isolated from Farmed Salmonids in Atlantic Canada (2000–2021)
Bacterial infection and antimicrobial resistance are important constraints in the production and sustainability of farmed salmonids. This retrospective study aimed to describe the frequency of bacterial isolates and antimicrobial resistance profiles in salmonid aquaculture in Atlantic Canada. Bacterial isolates and antimicrobial susceptibility testing (AST) results assessed by disk diffusion testing were summarized for 18,776 Atlantic salmon (Salmo salar) and rainbow trout (Oncorhynchus mykiss) samples from 2291 unique cases submitted to the Atlantic Veterinary College, Aquatic Diagnostic Services Bacteriology Laboratory from 2000 to 2021. Kidney was the most commonly submitted tissue (60.29%, n = 11,320), and these specimens were mostly submitted as swabs (63.68%, n = 11,957). The most prevalent pathogens detected in these cases were Yersinia ruckeri type 1 (5.54%, n = 127), Renibacterium salmoninarum (2.10%, n = 48), Aeromonas salmonicida (atypical) (1.66%, n = 38), and Pseudomonas fluorescens (1.22%, n = 28). Most bacterial isolates tested (n = 918) showed resistance to florfenicol, oxytetracycline, ormetoprim-sulfadimethoxine, and trimethoprim-sulfamethoxazole, but not to enrofloxacin. This report provides baseline data for antimicrobial surveillance programs that investigate emerging antimicrobial resistance trends in salmonid aquaculture in Atlantic Canada.
- 25 March 2022
- Published by MDPI AG in Veterinary Sciences
- Vol. 9 (4) , 159
Open AccessAntimicrobial Susceptibility Profiles of Bacteria Commonly Isolated from Farmed Salmonids in Atlantic Canada (2000–2021)
Bacterial infection and antimicrobial resistance are important constraints in the production and sustainability of farmed salmonids. This retrospective study aimed to describe the frequency of bacterial isolates and antimicrobial resistance profiles in salmonid aquaculture in Atlantic Canada. Bacterial isolates and antimicrobial susceptibility testing (AST) results assessed by disk diffusion testing were summarized for 18,776 Atlantic salmon (Salmo salar) and rainbow trout (Oncorhynchus mykiss) samples from 2291 unique cases submitted to the Atlantic Veterinary College, Aquatic Diagnostic Services Bacteriology Laboratory from 2000 to 2021. Kidney was the most commonly submitted tissue (60.29%, n = 11,320), and these specimens were mostly submitted as swabs (63.68%, n = 11,957). The most prevalent pathogens detected in these cases were Yersinia ruckeri type 1 (5.54%, n = 127), Renibacterium salmoninarum (2.10%, n = 48), Aeromonas salmonicida (atypical) (1.66%, n = 38), and Pseudomonas fluorescens (1.22%, n = 28). Most bacterial isolates tested (n = 918) showed resistance to florfenicol, oxytetracycline, ormetoprim-sulfadimethoxine, and trimethoprim-sulfamethoxazole, but not to enrofloxacin. This report provides baseline data for antimicrobial surveillance programs that investigate emerging antimicrobial resistance trends in salmonid aquaculture in Atlantic Canada.